Bioness Medical Acquires the PoNS (Portable Neuromodulation Stimulator) System Product Line

Medtronic Acquires SPR Therapeutics

May 20, 2026

Healthcare Services

Medtronic agreed to acquire SPR Therapeutics for approximately $650 million in cash to add SPR’s FDA-cleared Sprint (SPRINT) temporary peripheral nerve stimulation (PNS) technology to its neuromodulation/pain portfolio. Medtronic later completed the acquisition, integrating the SPRINT PNS System to expand minimally invasive, non-opioid chronic and acute pain treatment options.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.

Bioness Medical Acquires Assets and Business of Harmonic Bionics

June 18, 2025

Medical Devices

Bioness Medical, a neuro-rehabilitation technology company based in Valencia, California, has acquired the assets and business of Austin, Texas–based Harmonic Bionics, a developer of a bilateral upper-extremity robotic exoskeleton. The acquisition expands Bioness's product portfolio into upper-extremity robotics and will complement its existing gait and balance systems once regulatory clearance for the Harmonic device is obtained.

Accelmed Partners Acquires Bioventus' Bioness Advanced Rehabilitation Business

October 1, 2024

Medical Devices

Bioventus has signed a definitive agreement to sell the Advanced Rehabilitation business of its subsidiary Bioness to private equity firm Accelmed Partners for total cash consideration of $45 million (including up to $20 million in earn-outs). The divestiture reduces Bioventus' annual revenue by about $50 million and allows Bioventus to focus on its core business while Accelmed plans to invest in and expand the Bioness rehabilitation product line.

Electromedical Products International Acquires Pulvinar Neuro

March 17, 2022

Medical Devices

Electromedical Products International (EPI) has acquired Pulvinar Neuro, a research-oriented medical device company focused on closed-loop neuromodulation and digital therapeutics. The deal expands EPI's scientific and research capabilities to accelerate development and commercialization of Pulvinar's transcranial alternating current stimulation (tACS), individualized feedback stimulation, and cloud-enabled digital therapeutics.

Bioventus Acquires Bioness, Inc.

March 30, 2021

Medical Devices

Bioventus Inc. acquired Bioness, Inc. for $45 million in up-front consideration plus up to $65 million of contingent consideration, making Bioness a wholly‑owned subsidiary. The acquisition expands Bioventus' rehabilitation and neuromodulation product portfolio and R&D pipeline, and is expected to be accretive to revenue by leveraging Bioventus' global commercial infrastructure.